WHO ICTRP trial
A5282. A RANDOMIZED PHASE II TRIAL TO COMPARE AN HPV TEST-AND-TREAT STRATEGY TO…
PER-039-11 · Registro Peruano de Ensayos Clínicos (REPEC)
Key facts
| Trial ID | PER-039-11 |
|---|---|
| Public title | A5282. A RANDOMIZED PHASE II TRIAL TO COMPARE AN HPV TEST-AND-TREAT STRATEGY TO A CYTOLOGY-BASED STRATEGY FOR PREVENTION OF CIN 2+ IN HIV-INFECTED WOMEN. |
| Scientific title | A5282. A RANDOMIZED PHASE II TRIAL TO COMPARE AN HPV TEST-AND-TREAT STRATEGY TO A CYTOLOGY-BASED STRATEGY FOR PREVENTION OF CIN 2+ IN HIV-INFECTED WOMEN. |
| Primary sponsor | El Instituto Nacional de Alergia y Enfermedades Infecciosas (NIAID) de los Estados Unidos, |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Study type | Interventional |
| Phase | II |
| Countries | India;Malawi;Botswana;South Africa;Zambia;Zimbabwe;Haiti;Peru |
| Interventions | TO BE ELIGIBLE, PARTICIPANTS MUST HAVE NO HISTORY OF CERVICAL, VAGINAL OR VULVAR CANCER; NO PRIOR CERVICAL CRYOTHERAPY, CERVICAL CONIZATION, OR HYSTERECTOMY; AND NO PRIOR RECEIPT OF HPV VACCINES. THE SCREENING LABORATORY EVALUATIONS INCLUDE… |
| Registration date | Aug 17, 2011 |
| Target size | 80 |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: